{"entity":{"id":"nct06095141","kind":"trial","name":"Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency","aka":["PTCA199-6"],"tldr":"A phase 2/3 trial of cisplatin in pancreatic cancer, run by Fudan University, now recruiting.","summary":"Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency is a phase 2/3, interventional study registered as NCT06095141 by Fudan University, with a registry enrolment figure of 30 participants, started 2023-12-01 and due to reach its primary completion in 2025-10-31. Interventions recorded: Cisplatin. Conditions listed: Pancreatic Adenocarcinoma; Homologous Recombination Deficiency. Primary outcome: progression-free survival, PFS. Pancreatic eligibility wording from the registry: \"* Histologically or cytologically confirmed advanced pancreas adenocarcinoma\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06095141","url":"https://clinicaltrials.gov/study/NCT06095141"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac","brca-palb2-pdac"],"sections":[],"technologies":["cytotoxic-chemotherapy","platinum"],"targets":[],"drugs":["cisplatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06095141","phase":"2/3","setting":"Cisplatin Based Regimen to Patients With Advanced Pancreatic Cancer and Homologous Recombination Deficiency","sponsor":"Fudan University","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06095141/","neighbours":{"cancer":[{"id":"brca-palb2-pdac","kind":"cancer","name":"BRCA or PALB2-mutant pancreatic ductal adenocarcinoma","route":"/cancers/brca-palb2-pdac/"},{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"},{"id":"platinum","kind":"technology","name":"Platinum agents","route":"/technologies/platinum/"}],"drug":[{"id":"cisplatin","kind":"drug","name":"Cisplatin","route":"/drugs/cisplatin/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}